{name}
{subtitle}
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
city
~28 mi. (Goiânia, Brazil, +247 more cities)
facility
Local Institution
biomarker
ER Positive, +1 more biomarker
drug
anthracycline, +4 more drugs
drug type
chemotherapy, +2 more types
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
city
~28 mi. (Goiânia, Brazil, +262 more cities)
facility
Hospital Araujo Jorge; Departamento de Ginecologia E Mama
biomarker
ER Positive, +1 more biomarker
drug
giredestrant, +2 more drugs
drug type
hormone therapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~28 mi. (Goiânia, Brazil, +260 more cities)
facility
Hospital Araujo Jorge; Departamento de Ginecologia E Mama
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
city
~28 mi. (Goiânia, Brazil, +130 more cities)
facility
Hospital Araujo Jorge; Departamento de Ginecologia E Mama
biomarker
ER Negative, +2 more biomarkers
drug
atezolizumab, +3 more drugs
drug type
chemotherapy, +1 more type
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~28 mi. (Goiânia, Brazil, +142 more cities)
facility
Hospital das Clínicas UFG
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug